Screener
Relay Therapeutics, Inc. RLAY Asset turnover
Asset turnover at other companies
Other financials
Where this comes from
Calculated from Relay Therapeutics, Inc.’s reported figures.
Based on trailing twelve months.
The source filing: Relay Therapeutics, Inc.’s 10-Q, filed August 6, 2026. Open the filing →
- Filed
- Aug 6, 2026, 4:15 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-338056
FAQ
- What is Relay Therapeutics, Inc.'s asset turnover?
- Relay Therapeutics, Inc. (RLAY) reported asset turnover of 0× in Q2 2026.
- How has Relay Therapeutics, Inc.'s asset turnover changed year-over-year?
- Relay Therapeutics, Inc.'s asset turnover increased by 9.9% year-over-year, from 0× to 0×.
- What is the long-term trend for Relay Therapeutics, Inc.'s asset turnover?
- Over 5 years (2020 to 2025), Relay Therapeutics, Inc.'s asset turnover has grown at a -31.7% compound annual growth rate (CAGR), from 0.1× to 0×.
- What does asset turnover mean?
- Trailing-twelve-month revenue divided by average total assets. Measures how many dollars of sales each dollar of assets generates — the efficiency leg of the DuPont decomposition of ROE.
Ask your AI about Relay Therapeutics, Inc.'s asset turnover.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude